• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Liveblogging from Valeant Q3 2014

Anonymous

Guest
OK, the Valeant Q3 conference is just underway, after a brief delay... Something about a kerfuffle between Tage Ramakrishna and Bill Ackman over the last cronut on the breakfast buffet at the back of the room... Alright, then let's listen in...